1. Singhania, N, Bansal, S, Nimmatoori, DP, Ejaz, AA, McCullough, PA, Singhania, G. Current overview on hypercoagulability in COVID-19. Am J Cardiovasc Drugs. 2020;20(5):393–403. doi:10.1007/s40256-020-00431-z.
Google Scholar | Crossref | Medline2. Dobesh, PP, Trujillo, TC. Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID-19. Pharmacotherapy. 2020;40(11):1130–1151. doi:10.1002/phar.2465.
Google Scholar | Crossref | Medline3. Jiménez, D, García-Sanchez, A, Rali, P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196. doi:10.1016/j.chest.2020.11.005.
Google Scholar | Crossref | Medline4. Roberts, LN, Whyte, MB, Georgiou, L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347–1350. doi:10.1182/blood.2020008086.
Google Scholar | Crossref | Medline5. Patell, R, Bogue, T, Koshy, A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136(11):1342–1346. doi:10.1182/blood.2020007938.
Google Scholar | Crossref | Medline6. Rashidi, F, Barco, S, Kamangar, F, et al. Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: prospective results from a multi-center study. Thromb Res. 2021;198:135–138. doi:10.1016/j.thromres.2020.12.001.
Google Scholar | Crossref | Medline7. Giannis, D, Allen, SL, Tsang, J, et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021;137(20):2838–2847. doi:10.1182/blood.2020010529.
Google Scholar | Crossref | Medline8. Spyropoulos, AC, Levy, JH, Ageno, W, et al. Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–1865. doi:10.1111/jth.14929.
Google Scholar | Crossref | Medline9. Moores, LK, Tritschler, T, Brosnahan, S, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143–1163. doi:10.1016/j.chest.2020.05.559.
Google Scholar | Crossref | Medline10. American Society of Hematology . ASH guidelines on use of anticoagulation in patients with COVID-19. Date unknown. Accessed October 1, 2021. https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/ash-guidelines-on-use-of-anticoagulation-in-patients-with-covid-19#rec3.
Google Scholar11. Spyropoulos, AC, Ageno, W, Albers, GW, et al. Post-discharge prophylaxis with rivaroxaban reduces fatal and major thromboembolic events in medically ill patients. J Am Coll Cardiol. 2020;75(25):3140–3147. doi:10.1016/j.jacc.2020.04.071.
Google Scholar | Crossref | Medline12. Cohen, AT, Harrington, RA, Goldhaber, SZ, et al. Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med. 2016;375(6):534–544. doi:10.1056/NEJMoa1601747.
Google Scholar | Crossref | Medline | ISI13. Schünemann, HJ, Cushman, M, Burnett, AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198–3225. doi:10.1182/bloodadvances.2018022954.
Google Scholar | Crossref | Medline14. Ramacciotti, E, Agati, LB, CAlderaro, D, et al. Medically Ill hospitalized patients for COVID-19 thrombosis extended prophylaxis with rivaroxaban therapy: the MICHELLE trial. Presented at: European Society of Cardiology Virtual Congress; .
Google Scholar15. Kaatz, S, Ahmad, D, Spyropoulos, AC, Schulman, S; Subcommittee on Control of Anticoagulation . Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119–2126. doi:10.1111/jth.13140.
Google Scholar | Crossref | Medline